The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Metabolic phenotype of bladder cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · cited 1×
“Tumor cells can reactivate de novo lipid synthesis, highlighting the potential role of lipogenesis in cancer pathogenesis [79].”
BackgroundActivation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
ATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
Acid-Mediated Tumor Invasion: a Multidisciplinary Study
Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B., & Gillies, R. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4193 · Cited by 771
Metabolic profiles of cancer cells
Griffin, J. L., & Shockcor, J. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1390 · Cited by 725
Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586
Liu, Y., Cao, Y., Zhang, W., Bergmeier, S., Qian, Y., Akbar, H., Colvin, R., Ding, J., Tong, L., Wu, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0131 · Cited by 555
Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
Robey, R. B., & Hay, N. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.010 · Cited by 540
Regulation of tumor pH and the role of carbonic anhydrase 9
Swietach, P., Vaughan-Jones, R. D., & Harris, A. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9064-0 · Cited by 539
Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0482 · Cited by 432
Moving toward System Genetics through Multiple Trait Analysis in Genome-Wide Association Studies
Shriner, D. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00001 · Cited by 390
Favaro, E., Bensaad, K., Chong, M. G., Tennant, D. A., Ferguson, D. J. P., Snell, C., Steers, G., Turley, H., Li, J.-L., Günther, U. L., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.017 · Cited by 386
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer
Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjøt, L., Ramanathan, R., Hansen, T. B., Villadsen, S. B., Gao, S., Ostenfeld, M. S., Borre, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25461 · Cited by 367
Dyrskjøt, L., Ostenfeld, M. S., Bramsen, J. B., Silahtaroglu, A. N., Lamy, P., Ramanathan, R., Fristrup, N., Jensen, J. L., Andersen, C. L., Zieger, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4043 · Cited by 363
Buzzai, M., Bauer, D. E., Jones, R. G., DeBerardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208622 · Cited by 357
Inactivation of p53 and Pten promotes invasive bladder cancer
Puzio-Kuter, A. M., Castillo-Martin, M., Kinkade, C. W., Wang, X., Shen, T. H., Matos, T., Shen, M. M., Cordon-Cardo, C., & Abate-Shen, C. (2009) · Genes & Development · doi:10.1101/gad.1772909 · Cited by 329
Atsumi, T., Chesney, J. A., Metz, C. N., Leng, L., Donnelly, S. C., Makita, Z., Mitchell, R., & Bucala, R. (2002) · PubMed · Cited by 323
Boros, L. G., Puigjaner, J., Cascante, M., Lee, W. N., Brandes, J. L., Bassilian, S., Yusuf, F., Williams, R. D., Muscarella, P., Melvin, W. S., et al. (1997) · PubMed · Cited by 277
Pescador, N., Villar, D., Cifuentes, D., Garcia-Rocha, M., Ortiz-Barahona, A., Vazquez, S., Ordoñez, A., Cuevas, Y., Saez-Morales, D., Garcia-Bermejo, M. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009644 · Cited by 264
Langbein, S., Zerilli, M., zur Hausen, A., Staiger, W., Rensch-Boschert, K., Lukan, N., Popa, J., Ternullo, M. P., Steidler, A., Weiss, C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602962 · Cited by 261
Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
Platt, F. M., Hurst, C. D., Taylor, C. F., Gregory, W. M., Harnden, P., & Knowles, M. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0898 · Cited by 251
Cao, X., Fang, L., Gibbs, S., Huang, Y., Dai, Z., Wen, P., Zheng, X., Sadee, W., & Sun, D. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0291-9 · Cited by 221
Hoskin, P. J., Sibtain, A., Daley, F. M., & Wilson, G. D. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601260 · Cited by 217
Putluri, N., Shojaie, A., Vasu, V. T., Vareed, S. K., Nalluri, S., Putluri, V., Thangjam, G. S., Panzitt, K., Tallman, C. T., Butler, C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1154 · Cited by 203
Pelletier, J., Bellot, G., Gounon, P., Lacas-Gervais, S., Pouysségur, J., & Mazure, N. M. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00018 · Cited by 201
Raı̈s, B., Comin, B., Puigjaner, J., Brandes, J. L., Creppy, E., Saboureau, D., Ennamany, R., Paul Lee, W.-N., Boros, L. G., & Cascante, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00924-2 · Cited by 191
Pignot, G., Cizeron‐Clairac, G., Vacher, S., Susini, A., Tozlu, S., Vieillefond, A., Zerbib, M., Lidereau, R., Debre, B., Amsellem‐Ouazana, D., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27949 · Cited by 175
Phase II study of everolimus in metastatic urothelial cancer
Milowsky, M. I., Iyer, G., Regazzi, A. M., Al‐Ahmadie, H., Gerst, S. R., Ostrovnaya, I., Gellert, L. L., Kaplan, R., Garcia‐Grossman, I. R., Pendse, D., et al. (2013) · BJU International · doi:10.1111/j.1464-410x.2012.11720.x · Cited by 166
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
Jin, X., Yun, S., Jeong, P., Kim, I., Kim, W., & Park, S. (2014) · OncoTarget · doi:10.18632/oncotarget.1744 · Cited by 140
Somatic mutation of PTEN in bladder carcinoma
Aveyard, J. S., Skilleter, A., Habuchi, T., & Knowles, M. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690439 · Cited by 138
Ramos‐Montoya, A., Lee, W. P., Bassilian, S., Lim, S. K., Trebukhina, R. V., Kazhyna, M. V., Ciudad, C. J., Noé, V., Centelles, J. J., & Cascante, M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22227 · Cited by 136
Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
Wittmann, B. M., Stirdivant, S. M., Mitchell, M. W., Wulff, J. E., McDunn, J. E., Li, Z., Dennis-Barrie, A., Neri, B. P., Milburn, M. V., Lotan, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115870 · Cited by 136
Bladder Cancer Determination Via Two Urinary Metabolites: A Biomarker Pattern Approach
Huang, Z., Lin, L., Gao, Y., Chen, Y., Yan, X., Xing, J., & Hang, W. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.007922 · Cited by 131
Seront, E., Rottey, S., Sautois, B. R., Kerger, J. N., D'Hondt, L. A., Verschaeve, V., Canon, J. L., Dopchie, C., Vandenbulcke, J., Whenham, N., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds057 · Cited by 129
Yang, X. F., Cheng, Y., Li, P., Tao, J., Deng, X., Zhang, X., Gu, M., Lü, Q., & Yin, C. (2014) · Tumor Biology · doi:10.1007/s13277-014-2617-2 · Cited by 118
Phosphofructokinase: A mediator of glycolytic flux in cancer progression
Hasawi, N. A., Alkandari, M. F., & Luqmani, Y. A. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.05.007 · Cited by 116
Pasikanti, K. K., Esuvaranathan, K., Hong, Y., Ho, P. C., Mahendran, R., Raman Nee Mani, L., Chiong, E., & Chan, E. C. Y. (2013) · Journal of Proteome Research · doi:10.1021/pr4000448 · Cited by 113
Rousset, M., Zweibaum, A., & Fogh, J. (1981) · PubMed · Cited by 113
Conde, V. R., Oliveira, P. F., Nunes, A. R., Rocha, C. S. F., Ramalhosa, E., Pereira, J. A., Alves, M. G., & Silva, B. M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.007 · Cited by 107
Comı́n-Anduix, B., Boros, L. G., Marín, S., Boren, J., Callol-Massot, C., Centelles, J. J., Torres, J. L., Agell, N., Bassilian, S., & Cascante, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206150200 · Cited by 105
Shen, G., Zhang, F., Liu, X., & Zhang, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.09.040 · Cited by 101
microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells
Zhang, W. (2011) · Oncology Reports · doi:10.3892/or.2011.1245 · Cited by 93
NMR-based Metabolomic Analysis of Human Bladder Cancer
Cao, M., Zhao, L., Chen, H., et al. (2012) · Analytical Sciences · doi:10.2116/analsci.28.451 · Cited by 92
Turyn, J., Schlichtholz, B., Dettlaff‐Pokora, A., Presler, M., Goyke, E., Matuszewski, M., Kmieć, Z., Krajka, K., & Świerczyński, J. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-43500 · Cited by 92
Rousset, M., Chevalier, G., Rousset, J., Dussaulx, E., & Zweibaum, A. (1979) · PubMed · Cited by 86
Targeting glycogen metabolism in bladder cancer
Lew, C. R., Guin, S., & Theodorescu, D. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.111 · Cited by 84
Lee, W.-N. P., Guo, P., Lim, S., Bassilian, S., Lee, S. T., Boren, J., Cascante, M., Go, V. L. W., & Boros, L. G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602243 · Cited by 83
Jiang, F., Ma, S., Xue, Y., Hou, J., & Zhang, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.078 · Cited by 82
Regulation of Aerobic Glycolysis by microRNAs in Cancer.
Singh, P. K., Mehla, K., Hollingsworth, M. A., & Johnson, K. R. (2011) · PubMed · Cited by 70
Low- and High-Grade Bladder Cancer Determination via Human Serum-Based Metabolomics Approach
Bansal, N., Gupta, A. K., Mitash, N., Shakya, P. S., Mandhani, A., Mahdi, A. A., Sankhwar, S. N., & Mandal, S. K. (2013) · Journal of Proteome Research · doi:10.1021/pr400859w · Cited by 69
Liu, G., Gandara, D. R., Lara, P. N., Raghavan, D., Doroshow, J. H., Twardowski, P. W., Kantoff, P. W., Oh, W. K., Kim, K., & Wilding, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0050 · Cited by 67
Tripathi, P., Somashekar, B. S., Ponnusamy, M. P., Gursky, A. M., Dailey, S. M., Kunju, P., Lee, C. T., Chinnaiyan, A. M., Rajendiran, T. M., & Ramamoorthy, A. (2013) · Journal of Proteome Research · doi:10.1021/pr4004135 · Cited by 64
Zhao, W., Chang, C., Cui, Y., Zhao, X., Yang, J., Shen, L., Zhou, J., Hou, Z., Zhang, Z., Ye, C., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.535989 · Cited by 61
Metabolomics in bladder cancer: a systematic review.
Cheng, Y., Yang, X. F., Deng, X., Zhang, X., Li, P., Tao, J., Qin, C., Wei, J., & Lü, Q. (2015) · PubMed · Cited by 61
The Cyclin-Dependent Kinase (CDK) Inhibitor Flavopiridol Inhibits Glycogen Phosphorylase
Kaiser, A., Nishi, K., Gorin, F. A., Walsh, D. A., Bradbury, E. M., & Schnier, J. B. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2220 · Cited by 57
Schnier, J. B., Nishi, K., Monks, A. P., Gorin, F. A., & Bradbury, E. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01542-0 · Cited by 55
Goldstein, J., Austin, S. L., Boyette, K., Kanaly, A., Veerapandiyan, A., Rehder, C. W., Kishnani, P. S., & Bali, D. S. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181d94eaa · Cited by 52
Terashima, M., Fujita, Y., Togashi, Y., Sakai, K., Velasco, M. A. D., Tomida, S., & Nishio, K. (2014) · Oncotarget · doi:10.18632/oncotarget.2220 · Cited by 51
Chang, S., Lee, S., Lee, C., Kim, J. I., & Kim, Y.-W. (2000) · Urology · doi:10.1016/s0090-4295(99)00474-4 · Cited by 50
Distinct metabolic differences between various human cancer and primary cells
Dettmer, K., Vogl, F. C., Ritter, A. P., Zhu, W., Nürnberger, N., Kreutz, M. P., Oefner, P. J., Gronwald, W., & Gottfried, E. (2013) · Electrophoresis · doi:10.1002/elps.201300228 · Cited by 48
Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease
Guin, S., Pollard, C., Ru, Y., Lew, C. R., Duex, J. E., Dancik, G. M., Owens, C. R., Spencer, A., Knight, S., Holemon, H., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju062 · Cited by 47
Inhibition of Fatty-acid Synthase Suppresses P-AKT and Induces Apoptosis in Bladder Cancer
Jiang, B., Li, E., Lu, Y., Jiang, Q., Cui, D., Jing, Y., & Xia, S. (2012) · Urology · doi:10.1016/j.urology.2012.02.046 · Cited by 46
Luo, J., Xie, D., Liu, M., Chen, W., Liu, Y., Wu, G., Kung, H., Zeng, Y., & Guan, X. (2008) · International Journal of Cancer · doi:10.1002/ijc.23399 · Cited by 40
von Rundstedt, F.-C., Rajapakshe, K., Ma, J., Arnold, J. M., Gohlke, J., Putluri, V., Krishnapuram, R., Piyarathna, D. W. B., Lotan, Y., Gödde, D., et al. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.01.039 · Cited by 40
Afonso, J., Santos, L. L., Morais, A., Amaro, T., Longatto‐Filho, A., & Baltazar, F. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1121329 · Cited by 38
Shi, H., Jiang, H., Wang, L., Cao, Y., Liu, P., Xu, X., Wang, Y., Sun, L., & Niu, H. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1053666 · Cited by 37
Wang, X., Wu, G. J., Cao, G., Yang, L., Xu, H., Huang, J. J., & Hou, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3995 · Cited by 33
mTOR upregulation of glycolytic enzymes promotes tumor development
Zha, X., Sun, Q., & Zhang, H. (2011) · Cell Cycle · doi:10.4161/cc.10.7.15063 · Cited by 29
ZHENG, S.-S., Gao, J.-G., Liu, Z., ZHANG, X.-H., Wu, S., Weng, B., WANG, Y.-L., Hou, S., & Jiang, B. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4746 · Cited by 27
The route to personalized medicine in bladder cancer: where do we stand?
Massari, F., Ciccarese, C., Santoni, M., Brunelli, M., Conti, A., Modena, A., Montironi, R., Santini, D., Liang Cheng, C., Martignoni, G., et al. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0357-x · Cited by 17
Self-citationTargeting glycogen metabolism: a novel strategy to inhibit cancer cell growth?
Favaro, E., & Harris, A. L. (2013) · Oncotarget · doi:10.18632/oncotarget.841 · Cited by 17
Lipid Metabolism Profiling and Bladder Cancer
Beşiroğlu, H. (2015) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000154 · Cited by 7
Cited by
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer
Wang, J., Zhu, W., Han, J., Yang, X., Zhou, R., Lu, H., Yu, H., Yuan, W., Li, P., Tao, J., et al. (2021) · Cancer Communications · doi:10.1002/cac2.12158 · Cited by 313
The mechanism of Warburg effect-induced chemoresistance in cancer
Liu, C., Jin, Y., & Fan, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698023 · Cited by 177
Zhang, Y., Liu, Z., Wang, X., Jian, H., Xiao, H., & Wen, T. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00470-5 · Cited by 47
Metadata
- Authors
- Massari, F., Ciccarese, C., Santoni, M., Iacovelli, R., Mazzucchelli, R., Piva, F., Scarpelli, M., Berardi, R., Tortora, G., Lopez-Beltran, A., Cheng, L., & Montironi, R.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 45
- Pages
- 46-57
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2295358293
- Cited by
- 334
- References
- 84
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.